Cardiovascular Device Update articles from September 2007

Cardiovascular Device Update archives from September 2007

Boston Scientific: a buyout very much looking to happen?
September 1, 2007... Boston Scientific: a buyout very much looking to happen? By DON LONG Cardiovascular Device Update Executive Editor "You should've bought it when you saw it." That's the not really very catchy saying I recently happened to...

SCAAR likely (or maybe not) to remove scar on DES future.
September 1, 2007... SCAAR likely (or maybe not) to remove scar on DES future By DON LONG CDU Executive Editor There is no doubt concerning what was the "blockbuster" news out of this year's Congress of the European Society of Cardiology (Sophia...

Multimodality imaging to be used to seek out subclinical heart disease.
September 1, 2007... Multimodality imaging to be used to seek out subclinical heart disease A CDU Staff Report This year's annual meeting of the European Society of Cardiology provided the platform for unveiling the High Risk Plaque (HRP) BioImage Study...

Embrionic stems cells 'coaxed' to become cardiac muscle cells.(Report)
September 1, 2007... Embrionic stems cells 'coaxed' to become cardiac muscle cells By ANETTE BREINDL CDU Science Editor While embryonic stem cells can become any cell type in the body, getting them to become the specific cell type a researcher needs...

Successes, failures in cardio drug pipeline.(Company overview)
September 1, 2007... Successes, failures in cardio drug pipeline Editor's note: While Cardiovascular Device Update is obviously directed toward manufacturers of medical devices and organizations that track these companies, this sector of med-tech also should be...

International Report.(coverage of drug-eluting stents)
September 1, 2007... International report NICE nearing a final decision on halting payments for DES Cardiologists in the UK are fighting an effort by the government to block coverage of drug-eluting stents (DES) in the wake of safety concerns reported over...

At press time . . .(Edwards Lifesciences)
September 1, 2007... At press time . . . Edwards granted CE mark for SAPIEN transcatheter heart valve system Edwards Lifesciences (Irvine, California) in early September, the world leader in the science of tissue valves, reported receiving CE mark...

Acquisitions.
September 1, 2007... Acquisitions * CardioDynamics International (San Diego) reported the sale of its Vermed unit to Medical Device Partners (Regensburg, Germany), for $8 million in cash. Additionally, CardoDynamics secured a five-year supply agreement for...

Agreements.(business; medical)
September 1, 2007... Agreements * Cardiac Science, (Bothell, Washington) and US Lacrosse (USL; Baltimore), the national governing body for men's and women's lacrosse reported that they have formed analliance to increase the likelihood of surviving sudden...

Market updates.
September 1, 2007... Market updates CMS to re-examine non-reimbursement for artificial hearts Manufacturers of artificial hearts will take heart in the report last month by the Centers for Medicare & Medicaid Services (CMS; Atlanta) that it will re-examine...

Personnel File.
September 1, 2007... Personnel File * AngioDynamics (Queensbury, New York) reported that its board of directors has elected Vincent Bucci as its chairman. Bucci joined the AngioDynamics board in January 2007 when AngioDynamics acquired RITA Medical Systems....

Product pipeline.
September 1, 2007... Product pipeline FDA approves new device in Concentric Merci Retriever line Three years after winning FDA clearance for its original Merci Retriever — the first medical device cleared by the agency to remove blood clots from the...

Medtronic's Endeavor DES to go before FDA's circulatory systems panel in October.(drug-eluting stent; food and drug administration)(Brief article)
September 1, 2007... Medtronic's Endeavor DES to go before FDA's circulatory systems panel in October Medtronic (Minneapolis) reported that it has been informed by the FDA that an advisory panel will review the premarket approval (PMA) application for its...

AGA device FDA-approved for closure of VSD of heart.
September 1, 2007... At press time . . . AGA device FDA-approved for closure of VSD of heart A CDU Staff Report AGA Medical (Plymouth, Minnesota) thus far focused primarily on closing a type of hole in the heart called a patent forman ovale (PFO), a...